Fake medicines are now counted among the top money-making markets for crime groups in East Asia and the Pacific. This is the troubling news from a United Nations Office on Drugs and Crime (UNODC) report released Tuesday.
Guidance for Manufacturers : What is required to be ready to connect to the EMVS?
Brussels 16.04.13: The European Federation of Pharmaceutical Industries and Associations (EFPIA), with the support of its European Stakeholder Model partners, yesterday signed a contract with IT service provider Solidsoft to implement the European Medicines Ve
EFPIAs Director General Richard Bergström puts forward his views on the counterfeiting of medicines, the impact on patients, and what is being done to solve the problem.
Counterfeiting is an age old issue. It is now a global problem where every sector of our economy has been affected. However, the consequences are different when it comes to counterfeit medicines; the main concern is not so much the loss of revenue to our industry but the health of patients.
Deadline 15th October 2012
EPAA is offering a €3000 prize for an essay or article that shows awareness of the importance to promote alternative approaches in safety assessment and regulatory compliance testing. As this year the EPAA’s lead theme is “Global implementation of 3Rs methodologies through international cooperation” the article is expected to focus on existing and to be developed international initiatives on 3Rs in animal testing. Deadline for submissions is 15th October 2012.
The European Association of Hospital Pharmacists (EAHP) and European Federation of Pharmaceutical and Industry Associations (EFPIA) have recently agreed to work towards a joint vision on the future of medicines bar coding to the single unit administered in hospitals.